medigraphic.com

2018, Number S1

<< Back Next >>

Cuba y Salud 2018; 13 (S1)

Characterization of Pulmonary Tuberculosis in new cases and retreatment of the Sanatorium Hospital of Luanda

Alba VE, Tamayo CR

Language: Spanish
References: 19
Page: 343-348
PDF size: 853.53 Kb.


ABSTRACT

Objective: to evaluate the clinical epidemiological characteristics and the result of the treatment of pulmonary tuberculosis in the groups of new cases and retreatment, as well as the factors associated with the abandonment of antibacillary treatment in the Sanatorium Hospital of Luanda in the period 2014 and 2015 constitutes the objective of the present investigation.
Method: a descriptive, transversal investigation with an analytical component was carried out, for which a probabilistic sample of 400 cases divided into two groups in a 1:1 ratio was taken. The data was taken from the individual medical records.
Results: the retreatment group had a higher average age, 35.2 (SD ± 11.5) years. The male gender was the majority in both groups. Among the factors associated only HIV/AIDS showed significant differences. Among the groups with predominance in the new cases, four of the clinical manifestations showed significant differences. Hemoptysis, adenomegaly and dyspnea predominated in cases of retreatment. Positive sputum smear was greater in both groups. The complete treatment reached 61.0% in new cases and 42,0% in cases of retreatment. The abandonment of treatment was greater than 30% in both groups. Alcoholism showed association with dropout, adjusted OR: 1.90 (1.14-3.17).
Conclusions: the cases of retreatment with respect to new cases were older, fewer TB/HIV coinfected and clinical characteristics of chronic tuberculosis, with less successful antibacillary treatment results.


REFERENCES

  1. World Health Organization (WHO) Global Tuberculosis Report 2016. WHO/HTM/TB/2016.13. Geneva: Switzerland: WHO; 2016

  2. World Health Organization (WHO) Global Tuberculosis Report 2015. WHO/HTM/TB/2015.22. Geneva: Switzerland: WHO; 2015

  3. Valadas E, Gomes A, Sutre A, Brilha S, Wete A, Hänscheid T, et al Tuberculosis with malaria or HIV co-infection in a large hospital in Luanda, Angola, J Infect Dev Ctries 2013, 7(3):269-272.

  4. Caminero Luna José A. Guía de la Tuberculosis para Médicos Especialistas. Paris: Unión Internacional Contra la Tuberculosis y Enfermedades Respiratorias; 2003.

  5. Programa Nacional de Controlo da Tuberculose e Lepra. Angola (PNCTRA). Guia para o tratamento da Tuberculose, 3ra ed. Luanda:Ministério da Saúde; 2013.

  6. Korenromp EL, Scano F, Williams BG, Dye C, Nunn P. Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: an analytical review. Clin Infect Dis 2003, 37:101-112.

  7. Reechaipichitkul W, So-Ngern A, Chaimanee P. Treatment outcomes of new and previously-treated smear positive pulmonary tuberculosis at Srinagarind Hospital, a tertiary care center in northeast Thailand. J Med Assoc Thai. 2014;97(5):490-9.

  8. Unis Gisela, Wolowski Ribeiro A., Souza Esteves L, Sá Spie F, Dornelles Picon P, Dalla Costa ER, et al. Tuberculosis recurrence in a high incidence setting for HIV and tuberculosis in Brazil, BMC Infectious Diseases. [Internet]. 2014 [citado 28 Ene 2016]; 14:548 Disponible en: http://www.biomedcentral.con/1471-2334/14/548

  9. Ade S, Adjibodé O, Wachinou P, Toundoh N, Awanou B, Agodokpessi G, et al. Characteristics and Treatment Outcomes of Retreatment Tuberculosis Patients in Benin. Tuberculosis Research and Treatment [Internet]. 2016 [citado 20 Jun 2017]; 2016:7 Disponible en: https://www.hindawi.com/journals/trt/2016/1468631/

  10. Belchior AS, Arcêncio RA, Mainbourg EMT. Differences in the clinical-epidemiological profile between new cases of tuberculosis and retreatment cases after default. Rev Esc Enferm USP. 2016;50(4):619-625.

  11. Azis L, Jones-López EC, Ellner JJ. HIV-associated tuberculosis En: Volberding P, Greene W, Lange JMA, Gallant JE, Sewankambo N. Sande’s HIV/AIDS Medicine: Medical Management of AIDS 2013: 2nd Ed. Elsevier Inc., 2012. p. 225-247

  12. González Montaner LJ., González Montaner PJ. Tuberculosis. [Internet].Buenos Aires: BGB-Biogem; 2000. [citado 24 Jun 2016]. Disponible en: http://www. bgb-biogen.con/tuberculosis/indice.php#up

  13. Dangisso MH, Datiko DG, Lindtjørn B. Trends of Tuberculosis Case Notification and Treatment Outcomes in the Sidama Zone, Southern Ethiopia: Ten-Year Retrospective Trend Analysis in Urban-Rural Settings. PLoS ONE [Internet]. 2014 [citado 28 Jun 2017];9(12): e114225. Disponible en: https://www.ncbi.nlm.nih. gov/pmc/articles/PMC4252125/

  14. Takarinda KC, Sandy C, Masuka N, Hazangwe P, Choto RC, Mutasa-Apollo T, et al. Factors Associated with Mortality among Patients on TB Treatment in the Southern Region of Zimbabwe, 2013. Tuberculosis Research and Treatment [Internet]. 2017 [citado 28 Jun 2017]; [citado 28 Jun 2017]; 2017:6232071. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352882/

  15. Noeske J., Voelz N., Fon E., Abena JL. Early results of systematic drug susceptibility testing in pulmonary tuberculosis retreatment cases in Cameroon, BMC Research Notes [Internet]. 2012 [citado 20 Abril 2016]; 5:160 Disponible en: http://www.biomedcentral.con/1756-0500/5/160

  16. Bouton TC, Kwara A, Kudzawu S, Forson A. Epidemiology and Outcomes of Previously Treated Tuberculosis Patients at the Korle-Bu Teaching Hospital Chest Clinic in Accra, Ghana: A 6-year Retrospective Review. Open Forum Infect Dis [Internet]. 2016 [citado 28 Jun 2017]; 3 (suppl_1): 561. Disponible en: https://academic. oup.com/ofid/article/doi/10.1093/ofid/ofw172.424/2636931/Epidemiology-and-Outcomes-of-Previously-Treated

  17. Yoko JLM, Tumbo JM, Mills AB, Kabongo CD. Characteristics of pulmonary tuberculosis patients in Moses Kotane region North West Province, South Africa. South African Family Practice 2017; 59(2):78–81.

  18. Culqui DR, Munayco CV, Grijalva CG, Cayla JA, Horna-Campos O, Alva K, et al. Factores asociados al abandono de tratamiento antituberculoso convencional en Perú, Arch Bronconeumol. [Internet]. 2012;48(5):150-5. [Consultado 28 de Enero 2016]. Disponible en:http://www.archbronconeunol.org/es/factores-asociadosal- abandono-tratamiento/articulo/90128693/

  19. Kigozi G, Heunis C, Chikobvu P, Botha S, van Rensburg D. Factors influencing treatment default among tuberculosis patients in a high burden province of South Africa. International Journal of Infectious Diseases 2017; 54 (2017): 95–102.




2020     |     www.medigraphic.com